Radiopharm Theranostics Limited (OTC:RDPTF) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Aaron Laurita Other companies: Immuron Limited (Chief Financial Officer · Since at least Feb 9, 2026) | Chief Financial Officer · Since at least Mar 18, 2026 |
| Dimitris Voliotis Other companies: Zentalis Pharmaceuticals, Inc. (SVP, Clinical Development · Apr 3, 2020 – Feb 10, 2022 · Past) | Chief Medical Officer · Since at least Mar 18, 2026 |
| Noel Donnelly Other companies: PepGen Inc. (Chief Financial Officer · Since at least May 5, 2022) | Director · Since at least Mar 18, 2026 |
| Barbara Lani | VP Quality Affairs · Since at least Nov 5, 2026 |
| Bruce Michael Goodwin | Director · Since at least Mar 18, 2026 |
| Donna Supko | VP Regulatory Affairs · Since at least Nov 4, 2026 |
| Emily Love-Leon | VP Clinical Operations · Since at least Nov 4, 2026 |
| Hester Larkin | Non - Executive Director · Since at least Mar 18, 2026 |
| Hitesh Goel | Head of Project Management · Since at least Nov 5, 2026 |
| Ian Turner | Non - Executive Director · Since at least Mar 18, 2026 |
| John M. Viglotti | SVP Corporate Services · Nov 5, 2025 – Nov 5, 2026 · Past |
| Levente Meszaros | VP Preclinical and Translational Science · Since at least Nov 5, 2026 |
| Melissa Thomas | VP Portfolio Program Lead · Since at least Nov 5, 2026 |
| Paul Hopper | Executive Chairman · Since at least Mar 18, 2026 |
| Riccardo Canevari | Managing Director and CEO · Since at least Mar 18, 2026 |
| Sherin Al-Safadi | VP Medical and Corporate Affairs · Since at least Nov 5, 2026 |
| Vimal Patel | VP CMC · Since at least Nov 5, 2026 |